Advertisement
Earnings Recap

OMRNY Earnings Miss: Stock Falls 3.3% After Weak Q2 2026 Results

Key Points

OMRNY missed Q2 2026 earnings badly with EPS down 39% and revenue down 38%.

Stock fell 3.3% to $36.32 after disappointing results.

Meyka AI rates OMRNY B-grade with neutral hold recommendation.

Next earnings report scheduled for July 23, 2026.

Be the first to rate this article

OMRNY (OMRON Corporation) delivered disappointing OMRNY Q2 earnings results on (May 14, 2026), missing analyst expectations on both fronts. The industrial automation company reported earnings per share of $0.4563, falling 39.16% short of the $0.75 estimate. Revenue came in at $970.97 million, representing a 38.13% miss against the $1.57 billion forecast. The weak performance triggered an immediate market reaction, with OMRNY stock sliding 3.33% to close at $36.32.

Advertisement

OMRNY Earnings Preview: EPS and Revenue Expectations

OMRON Corporation faced significant headwinds in Q2 2026, with actual results falling dramatically short of Wall Street projections. The company’s EPS of $0.4563 represented one of the weakest quarters in recent history, trailing estimates by nearly 40 percentage points. Revenue of $970.97 million also disappointed, missing by $598 million compared to analyst expectations.

This marks a concerning trend for the industrial automation leader. Comparing to the prior quarter (February 2026), OMRNY showed deterioration across both metrics, with EPS declining from $0.46 and revenue falling from $1.41 billion.

OMRON Corporation Stock Valuation and Key Financial Metrics

OMRNY stock trades at a P/E ratio of 33.09, reflecting investor skepticism following the earnings miss. The company maintains a market cap of $7.16 billion with 196.6 million shares outstanding. Technical indicators show mixed signals, with RSI at 56.97 suggesting neutral momentum and ADX at 39.74 indicating a strong downtrend.

Meyka AI rates OMRNY with a grade of B, suggesting a neutral hold position. The stock’s 50-day moving average sits at $31.50, while the 200-day average stands at $28.24, indicating the stock remains above longer-term support levels despite recent weakness.

What to Watch in OMRON Corporation Earnings Report

The earnings miss raises questions about OMRON Corporation’s operational efficiency and market demand. Gross profit margins remain healthy at 45.75%, but operating margins compressed to 7.83%, signaling cost pressures. The company’s free cash flow per share of $40.62 provides some cushion, though down significantly from prior periods.

Investors should monitor management commentary on demand recovery and cost-cutting initiatives. The next earnings announcement is scheduled for (July 23, 2026), giving the company time to stabilize operations and provide updated guidance.

OMRNY Stock Forecast and Analyst Outlook

Analysts project OMRNY stock could reach $32.90 quarterly and $32.62 monthly, suggesting limited upside from current levels. The stock’s year-to-date performance of 44.07% masks underlying weakness in recent quarters. With a dividend yield of 1.86%, income-focused investors may find some appeal despite operational challenges.

The industrial automation sector faces cyclical pressures, and OMRNY’s miss suggests the company is not immune to broader economic headwinds. Recovery will depend on management’s ability to restore profitability and demonstrate demand stabilization in upcoming quarters.

Advertisement

Final Thoughts

OMRNY’s Q2 2026 earnings miss represents a significant setback for OMRON Corporation, with both EPS and revenue falling roughly 39% and 38% short of expectations respectively. The stock’s 3.3% decline reflects investor disappointment with operational performance. While the company maintains a solid balance sheet and dividend, the earnings deterioration signals operational challenges that require immediate management attention. Investors should await the next earnings report on (July 23, 2026) for signs of recovery before reassessing positions.

FAQs

Did OMRNY beat or miss Q2 2026 earnings?

OMRNY missed significantly. EPS fell 39% to $0.46 versus $0.75 estimate; revenue dropped 38% to $971M versus $1.57B forecast.

How did OMRNY stock react to the earnings miss?

OMRNY stock declined 3.33% to $36.32 on May 14, 2026, following disappointing earnings and weak forward guidance.

What is Meyka AI’s rating for OMRNY stock?

Meyka AI rates OMRNY as grade B with a neutral hold position, scoring 62.65 overall based on financial metrics and forecasts.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)